Cell & Gene Therapy Investor Forum

Investing in ATMP: From Breakthroughs to Scalable Therapies

– An NLSD & CCRM Nordic Investor Event

ATMP is at an inflection point, where significant scientific progress is now meeting increasing expectations on scalability, cost, and commercial viability. This creates a growing need for stronger alignment across the ecosystem – bringing together developers, investors, technology providers, and enabling organizations.

This joint event, hosted by NLSD and CCRM Nordic, is a dedicated investor-focused session designed to connect capital with the ATMP ecosystem. It offers a unique opportunity for investors to gain a structured understanding of the field, explore the latest developments, and engage directly with companies and experts shaping the future of cell and gene therapy.

Who should attend?

• Investors who are either new or experienced in ATMP
• Developers of ATMPs and supportive technology

Why attend?

• Get experts view of where the ATMP field is today – and where it is heading
• Understand what has changed in recent years and what still remains challenging
• Learn what makes an ATMP company investable
• Explore technologies enabling scalability
• Connect directly with leading companies and investors in the space

Event details

Date: Monday, September 7
Location: Kistamässan, Stockholm
Time: 13:30 – 17:30

This event is part of NLSD and is open to NLSD ticket holders only.

Agenda

13:30 – 13:45: Welcome and introduction

13:45 – 14:15: Keynote, “New developments and key research findings“
An overview of recent scientific, technological and clinical progress in ATMP, including key learnings from past successes and challenges.

14:15 – 14:45: Presentation, “Breaking the ATMP cost barrier – technologies enabling scalable therapies“
Presentation on manufacturing innovations and technologies that reduce cost of goods and enable commercially viable products. Followed by Q&A.

14:45 – 15:00: Break

15:00 – 15:45: Panel “Investing in ATMP – what investors actually look for“
A candid discussion on investment criteria, risks, and opportunities in ATMP, including lessons learned from past failures and what defines an investable company today. Followed by Q&A.

15:45 – 16:00: Break

16:00 – 17:00
Company pitch sessions
Selected ATMP and supportive technology companies present their opportunities to investors.

17:00 – 17:30
Networking and drinks
(Buses to dinner depart afterwards)

Registration

Please follow this link to register for free: Billetto

Kindly note that this event is intended exclusively for investors and developers within ATMPs and enabling technologies who hold a valid NLSD ticket. We reserve the right to decline registrations if needed and will communicate any such decisions well in advance.

About CCRM Nordic
CCRM Nordic is a leading organization dedicated to advancing research, development, and commercialization of advanced therapy medicinal products (ATMPs). With a focus on innovation and collaboration, CCRM Nordic strives to accelerate the translation of scientific discoveries into tangible therapies that address unmet medical needs. Learn more about CCRM Nordic: ccrmnordic.se

Event Contact:

Stephanie Mattsson, Director Venture Development, CCRM Nordic

stephanie.mattsson@ccrmnordic.se

+46 730 259089